What Does SCWorX (WORX) Do? — Comprehensive Look at Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters
SCWorX (WORX) is a company that specializes in standardizing hospital asset procurement data and providing a healthcare supply chain cloud platform. This report provides an in-depth look at its IT solutions contract performance, forward stock outlook, and a detailed market cap analysis of healthcare information-related stocks.
🏢 What kind of company is SCWorX?
SCWorX is an IT engineering firm that restructures the procurement specification data of medical consumables used by public health authorities and large hospital foundations into a consistent data model. It links fragmented hospital purchasing information into a single cloud portal to ensure procurement transparency.
Its core business is providing a hospital procurement data integration and management platform as a service. It also generates ancillary operating revenue by collecting maintenance fees and consulting commissions tied to medical device unique identifier (UDI) integration.
How does SCWorX make money?| Business Segment | Revenue Share | Description |
|---|---|---|
| Supply Chain Data Solutions | Core | Annual subscription license fees received for integrating data standardization software with hospital information systems |
| Data Quality Consulting | Secondary | Consulting commissions for medical device supply chain database cleansing and catalog optimization projects |
The current revenue mix is generated from multiple streams, including supply chain software subscriptions from large general hospitals and remote database cleansing service fees. The company is a relatively small-cap IT services provider, making the volume of new supply chain contracts with major medical groups and tight control of selling, general, and administrative (SG&A) expenses critical levers. By optimizing its cloud-based IT platform, it steadily controls data management costs.
📐 SCWorX Market Cap and Company Scale
Its market capitalization stands at $1.2M, and its workforce size is 9 people.
The company sits within the micro-cap segment of the hospital IT network and medical software industry, where capital scale is limited. It is characterized by very high short-term share price volatility, driven by news flow on multi-year supply chain license contracts with major hospital foundations, as well as disclosures of non-compliance with minimum bid price requirements on US exchanges.
Outlook and Share Price Trends for SCWorXThe forward business outlook is closely tied to the pace of US healthcare procurement transparency legislation and the depth of penetration of its cloud data platform into mid-sized hospitals. While the digital demand trend toward hospital supply chain efficiency is a positive factor, intensifying competition with large healthcare IT rivals for market share and the risk of exchange delisting due to non-compliance with Nasdaq listing maintenance requirements are cited as key future share price swing factors.
- Speed of new data platform sign-ups among major US medical networks and general hospital chains
- Execution and submission outcomes of private placement capital funding agreements aimed at resolving Nasdaq listing standard violations
⚔️ SCWorX Core Strengths and Risks
Its differentiated data standardization technology for medical supplies databases is a strength, but chronic losses stemming from delays in securing new general hospital contracts and the risk of exchange delisting are weaknesses.
💪 Core Strengths
⚠️ Core Risks
SCWorX Competitors and Related (Beneficiary) Stocks
Companies viewed as direct competitors within the broader healthcare information and IT services industry include MNDR, which operates a mobile health platform; HCTI, which supplies IT network construction solutions; and ZCMD, which handles Chinese healthcare media. Additionally, MGRX, which runs a men's health portal, and ACON, which designs biocomputer chips, are categorized as related stocks.
✅ Investor Checklist for SCWorX
The key investment review items for SCWorX (WORX), which seeks to break into the US smart healthcare distribution IT market with its differentiated hospital procurement data standardization platform, are as follows.
| Checklist | Item to Verify | Current Status |
|---|---|---|
| Data Contract Volume | Growth in annual data platform sign-ups from US general hospitals and large hospital foundations | Growth underway |
| Listing Maintenance Review | Status of Nasdaq hearing preparations and financial settlements to resolve the minimum bid price deficiency notice | Review underway |
| System Maintenance Costs | Control of cloud data hosting costs and labor cost rates for IT analytics personnel | Steadily controlled |
If the signing of new licenses with general hospitals is delayed over the long term, deepening operating losses, or if delisting is finalized following a failed exchange review, there is a risk of significant impairment to investment value.
SCWorX occupies a niche market in hospital supply chain efficiency, but given its persistent losses and delisting threat, it is prudent to approach the stock with staggered, cautious purchases.
⚔️ SCWorX Core Strengths and Risks
Its differentiated data standardization technology for medical supplies databases is a strength, but chronic losses stemming from delays in securing new general hospital contracts and the risk of exchange delisting are weaknesses.
💪 Core Strengths
⚠️ Core Risks
SCWorX Competitors and Related (Beneficiary) Stocks
Companies viewed as direct competitors within the broader healthcare information and IT services industry include MNDR, which operates a mobile health platform; HCTI, which supplies IT network construction solutions; and ZCMD, which handles Chinese healthcare media. Additionally, MGRX, which runs a men's health portal, and ACON, which designs biocomputer chips, are categorized as related stocks.
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| Mobile health Network Solutions | $1.42 | -7.2% | $1.7M | - | 0.1 | -47.26% | - | |
| Healthcare Triangle Inc | $0.79 | -7.8% | $11.8M | - | 0.1 | -57.32% | - | |
| Zhongchao Inc | $0.85 | -3.8% | $1.0M | - | 0.0 | -31.98% | - |
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| Mangoceuticals Inc | $0.41 | +5.3% | $8.9M | - | 0.6 | -94.42% | - | |
| Aclarion Inc | $2.35 | +2.6% | $6.8M | - | 0.3 | -58.97% | - |
✅ Investor Checklist for SCWorX
The key investment review items for SCWorX (WORX), which seeks to break into the US smart healthcare distribution IT market with its differentiated hospital procurement data standardization platform, are as follows.
| Checklist | Item to Verify | Current Status |
|---|---|---|
| Data Contract Volume | Growth in annual data platform sign-ups from US general hospitals and large hospital foundations | Growth underway |
| Listing Maintenance Review | Status of Nasdaq hearing preparations and financial settlements to resolve the minimum bid price deficiency notice | Review underway |
| System Maintenance Costs | Control of cloud data hosting costs and labor cost rates for IT analytics personnel | Steadily controlled |
If the signing of new licenses with general hospitals is delayed over the long term, deepening operating losses, or if delisting is finalized following a failed exchange review, there is a risk of significant impairment to investment value.
SCWorX occupies a niche market in hospital supply chain efficiency, but given its persistent losses and delisting threat, it is prudent to approach the stock with staggered, cautious purchases.